Infants with Tyrosinemia Type 1: Should phenylalanine be supplemented?

Tyrosinemia type 1 (HT1) is an inborn error of tyrosine catabolism caused by fumarylacetoacetase deficiency. Biochemically, this results in accumulation of toxic metabolites including succinylacetone. Clinically, HT1 is characterized by severe liver, kidney, and neurological problems. Treatment with...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:JIMD Rep
Main Authors: van Vliet, Danique, van Dam, Esther, van Rijn, Margreet, Derks, Terry G. J., Venema-Liefaard, Gineke, Hitzert, Marrit M., Lunsing, Roelineke J., Heiner-Fokkema, M. Rebecca, van Spronsen, Francjan J.
Format: Artigo
Sprog:Inglês
Udgivet: Springer Berlin Heidelberg 2014
Fag:
Article
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4361924/
https://ncbi.nlm.nih.gov/pubmed/25256450
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/8904_2014_358
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker